Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer. ICIs have a unique side effect profile, generally caused by inflammatory tissue damage, with clinical features similar to autoimmune conditions. Acute kidney injury from ICIs has been well studied; incidence ranges from...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Sehrish, Arani, Naszrin, Parvathareddy, Vishnu, Tchakarov, Amanda, Abdelrahim, Maen, Suarez-Almazor, Maria, Zhang, Jianjun, Gibbons, Don Lynn, Heymach, John, Altan, Mehmet, Abudayyeh, Ala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479603/
https://www.ncbi.nlm.nih.gov/pubmed/37675380
http://dx.doi.org/10.3389/fneph.2023.1168614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479603/
https://www.ncbi.nlm.nih.gov/pubmed/37675380
http://dx.doi.org/10.3389/fneph.2023.1168614

Ejemplares similares